☰

Robert N Collins, Ph.D./MASP/BSc (Honours) - Publications

Affiliations: 
2018- DRDC Toronto 
Area:
(Priming, Memory, Judgment, Prediction)
Website:
https://www.linkedin.com/in/collinrn/v
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

6/75 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Collins RN, Mandel DR, Schywiola SS. Political Identity Over Personal Impact: Early U.S. Reactions to the COVID-19 Pandemic. Frontiers in Psychology. 12: 607639. PMID 33833708 DOI: 10.3389/fpsyg.2021.607639  0.414
2020 Collins RN, Milliken B, Jamieson RK. MINERVA-DE: An instance model of the deficient processing theory Journal of Memory and Language. 115: 104151. DOI: 10.1016/J.Jml.2020.104151  0.535
2019 Collins RN, Milliken B. The repetition decrement effect in recognition memory: The influence of prime-target spacing. Acta Psychologica. 197: 94-105. PMID 31128518 DOI: 10.1016/J.Actpsy.2019.05.009  0.549
2018 Collins RN, Rosner TM, Milliken B. Remembering 'primed' words: The effect of prime encoding demands. Canadian Journal of Experimental Psychology. 72: 9-23. PMID 29517265 DOI: 10.1037/cep0000138.  0.537
2018 Collins RN, Rosner TM, Milliken B. Remembering 'primed' words: The effect of prime encoding demands. Canadian Journal of Experimental Psychology = Revue Canadienne De Psychologie Experimentale. 72: 9-23. PMID 29517265 DOI: 10.1037/Cep0000138  0.553
2011 Chapieski L, Evankovich K, Hiscock M, Collins R. Everyday verbal memory and pediatric epilepsy. Epilepsy & Behavior : E&B. 21: 285-90. PMID 21620770 DOI: 10.1016/J.Yebeh.2011.04.055  0.306
Low-probability matches (unlikely to be authored by this person)
2016 Martin R, Cirino P, Hiscock M, Schultz R, Collins R, Chapieski L. Risks and benefits of epilepsy surgery in a pediatric population: Consequences for memory and academic skills. Epilepsy & Behavior : E&B. 62: 189-196. PMID 27494354 DOI: 10.1016/J.Yebeh.2016.06.028  0.188
2020 Shin N, Stubbs M, Koblish H, Yue EW, Soloviev M, Douty B, He Wang K, Wang Q, Gao M, Feldman P, Yang G, Hall L, Hansbury M, O'Connor S, Leffet L, ... Collins R, et al. Parsaclisib Is a Next-Generation PI3Kδ Inhibitor With Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy. The Journal of Pharmacology and Experimental Therapeutics. PMID 32345620 DOI: 10.1124/jpet.120.265538  0.12
2013 Jacquet L, Stephenson E, Collins R, Patel H, Trussler J, Al-Bedaery R, Renwick P, Ogilvie C, Vaughan R, Ilic D. Strategy for the creation of clinical grade hESC line banks that HLA-match a target population. Embo Molecular Medicine. 5: 10-7. PMID 23161805 DOI: 10.1002/emmm.201201973  0.112
2018 Stubbs MC, Burn TC, Sparks RB, Maduskuie T, Diamond S, Rupar M, Wen X, Volgina A, Zolotarjova N, Waeltz P, Favata M, Jalluri R, Liu H, Liu XM, Li J, ... Collins R, et al. The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30206163 DOI: 10.1158/1078-0432.CCR-18-0098  0.107
2017 Stein EM, DiNardo CD, Pollyea DA, Fathi AT, Roboz GJ, Altman JK, Stone RM, DeAngelo DJ, Levine RL, Flinn IW, Kantarjian HM, Collins R, Patel MR, Frankel AE, Stein A, et al. Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia. Blood. PMID 28588020 DOI: 10.1182/Blood-2017-04-779405  0.102
2019 Pollyea DA, Tallman MS, de Botton S, Kantarjian HM, Collins R, Stein AS, Frattini MG, Xu Q, Tosolini A, See WL, MacBeth KJ, Agresta SV, Attar EC, DiNardo CD, Stein EM. Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia. Leukemia. PMID 30967620 DOI: 10.1038/S41375-019-0472-2  0.1
2005 Brodmerkel CM, Huber R, Covington M, Diamond S, Hall L, Collins R, Leffet L, Gallagher K, Feldman P, Collier P, Stow M, Gu X, Baribaud F, Shin N, Thomas B, et al. Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. Journal of Immunology (Baltimore, Md. : 1950). 175: 5370-8. PMID 16210643  0.099
2017 Kurtz SE, Eide CA, Kaempf A, Khanna V, Savage SL, Rofelty A, English I, Ho H, Pandya R, Bolosky WJ, Poon H, Deininger MW, Collins R, Swords RT, Watts J, et al. Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies. Proceedings of the National Academy of Sciences of the United States of America. PMID 28784769 DOI: 10.1073/Pnas.1703094114  0.098
2020 Burd A, Levine RL, Ruppert AS, Mims AS, Borate U, Stein EM, Patel P, Baer MR, Stock W, Deininger M, Blum W, Schiller G, Olin R, Litzow M, Foran J, ... ... Collins R, et al. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial. Nature Medicine. PMID 33106665 DOI: 10.1038/s41591-020-1089-8  0.09
2016 Lu Z, Xie J, Wu G, Shen J, Collins R, Chen W, Kang X, Luo M, Zou Y, Huang LJ, Amatruda JF, Slone T, Winick N, Scherer PE, Zhang CC. Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation. Nature Medicine. PMID 27941793 DOI: 10.1038/Nm.4252  0.088
2020 Stein EM, Fathi AT, DiNardo CD, Pollyea DA, Roboz GJ, Collins R, Sekeres MA, Stone RM, Attar EC, Frattini MG, Tosolini A, Xu Q, See WL, MacBeth KJ, de Botton S, et al. Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial. The Lancet. Haematology. PMID 32145771 DOI: 10.1016/S2352-3026(19)30284-4  0.085
2020 Covington M, He X, Scuron M, Li J, Collins R, Juvekar A, Shin N, Favata M, Gallagher K, Sarah S, Xue CB, Peel M, Burke K, Oliver J, Fay B, et al. Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases. European Journal of Pharmacology. 173505. PMID 32861662 DOI: 10.1016/j.ejphar.2020.173505  0.083
2021 Chen P, Redd L, Schmidt Y, Koduru P, Fuda F, Montgomery-Goecker C, Kumar K, Xu-Monette Z, Young K, Collins R, Chen W. MYC protein expression does not correlate with MYC abnormalities detected by FISH but predicts an unfavorable prognosis in de novo acute myeloid leukemia. Leukemia Research. 106: 106584. PMID 33933715 DOI: 10.1016/j.leukres.2021.106584  0.082
2015 Tusé D, Ku N, Bendandi M, Becerra C, Collins R, Langford N, Sancho SI, López-Díaz de Cerio A, Pastor F, Kandzia R, Thieme F, Jarczowski F, Krause D, Ma JK, Pandya S, et al. Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma. Biomed Research International. 2015: 648143. PMID 26425548 DOI: 10.1155/2015/648143  0.081
2021 Bӧhm JW, Sia KCS, Jones C, Evans K, Mariana A, Pang I, Failes T, Zhong L, Mayoh C, Landman R, Collins R, Erickson SW, Arndt G, Raftery MJ, Wilkins MR, et al. Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia. Leukemia. PMID 33895784 DOI: 10.1038/s41375-021-01248-8  0.08
2019 Zhang H, Savage S, Schultz AR, Bottomly D, White L, Segerdell E, Wilmot B, McWeeney SK, Eide CA, Nechiporuk T, Carlos A, Henson R, Lin C, Searles R, Ho H, ... ... Collins R, et al. Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms. Nature Communications. 10: 244. PMID 30651561 DOI: 10.1038/S41467-018-08263-X  0.08
2010 Fridman JS, Scherle PA, Collins R, Burn TC, Li Y, Li J, Covington MB, Thomas B, Collier P, Favata MF, Wen X, Shi J, McGee R, Haley PJ, Shepard S, et al. Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050. Journal of Immunology (Baltimore, Md. : 1950). 184: 5298-307. PMID 20363976 DOI: 10.4049/jimmunol.0902819  0.08
2018 Stein EM, DiNardo CD, Fathi AT, Pollyea DA, Stone RM, Altman JK, Roboz GJ, Patel MR, Collins R, Flinn IW, Sekeres MA, Stein AS, Kantarjian HM, Levine RL, Vyas P, et al. Molecular remission and response patterns in patients with mutant- acute myeloid leukemia treated with enasidenib. Blood. PMID 30510081 DOI: 10.1182/Blood-2018-08-869008  0.076
2018 Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, He L, Chen Y, Chen H, Luo W, Lu Z, Xie J, Churchill H, Xu Y, Zhou Z, ... ... Collins R, et al. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature. PMID 30333625 DOI: 10.1038/S41586-018-0615-Z  0.074
2013 Boles J, DeNicola M, Collins R, Garcia R, Patel S, Satayasoontorn K, Tirado CA. A Chronic Myelogenous Leukemia (CML) Case with a Cryptic Insertion of the ABL1 Gene of Chromosome 9 into 22 Resulting in a Fusion Signal on the Derivative 22: 46,XY.ish ins(22;9)(q11.2;q34q34)BCR+,ABL1. Journal of the Association of Genetic Technologists. 39: 21-2. PMID 26030620  0.073
2016 Garcia-Manero G, Fenaux P, Al-Kali A, Baer MR, Sekeres MA, Roboz GJ, Gaidano G, Scott BL, Greenberg P, Platzbecker U, Steensma DP, Kambhampati S, Kreuzer KA, Godley LA, Atallah E, ... Collins R, et al. Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial. The Lancet. Oncology. PMID 26968357 DOI: 10.1016/S1470-2045(16)00009-7  0.07
2007 Brewster AM, Lee JJ, Clayman GL, Clifford JL, Reyes MJ, Zhou X, Sabichi AL, Strom SS, Collins R, Meyers CA, Lippman SM. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 1974-8. PMID 17513803 DOI: 10.1200/Jco.2006.05.9873  0.07
2011 Berenson JR, Boccia R, Lopez T, Warsi GM, Argonza-Aviles E, Lake S, Ericson SG, Collins R. Results of a multicenter open-label randomized trial evaluating infusion duration of zoledronic acid in multiple myeloma patients (the ZMAX trial). The Journal of Supportive Oncology. 9: 32-40. PMID 21465735  0.068
2009 Tirado CA, Henderson S, Uddin N, Stewart E, Iyer S, Ratner IM, Matthews E, Doolittle J, Garcia R, Valdez F, Dallaire S, Appleberry T, Payne D, Collins R. Cytogenetic and molecular characterization of a partial trisomy 2p arising from inverted duplication of 2p with terminal deletion of 2pter. American Journal of Medical Genetics. Part A. 149: 2507-12. PMID 19876903 DOI: 10.1002/ajmg.a.33080  0.067
2020 Bergstrom CP, Dahiya S, Chen W, Zhang CC, Zhu H, Yan J, Madanat Y, Patel P, Vusirkala M, Ramakrishnan P, Rizvi S, Chung S, Awan F, Anderson LD, Collins R, et al. The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement. Leukemia Research. 100: 106480. PMID 33285315 DOI: 10.1016/j.leukres.2020.106480  0.066
2017 Shabsovich D, Schiller G, Naeini Y, Collins R, Tirado CA. Novel Cytogenetic Findings in a Case of Mixed Phenotype Acute Leukemia within the Context of a Complex Karyotype. Journal of the Association of Genetic Technologists. 43: 20-22. PMID 28459703  0.065
2003 Cumbaa CA, Lauricella A, Fehrman N, Veatch C, Collins R, Luft J, DeTitta G, Jurisica I. Automatic classification of sub-microlitre protein-crystallization trials in 1536-well plates. Acta Crystallographica. Section D, Biological Crystallography. 59: 1619-27. PMID 12925793 DOI: 10.1107/S0907444903015130  0.063
2023 Zhang C, Chu A, Boriack R, Collins R, Xu J, Oliver D, Zheng R, Rakheja D, Chen W. Serum D-2-hydroxyglutarate and the ratio of D-2HG/L-2HG predict mutation in acute myeloid leukemia. Ejhaem. 4: 723-727. PMID 37601838 DOI: 10.1002/jha2.723  0.062
2011 Patricios J, Collins R, Branfield A, Roberts C, Kohler R. The sports concussion note: should SCAT become SCOAT? British Journal of Sports Medicine. 46: 198-201. PMID 22144001 DOI: 10.1136/bjsports-2011-090386  0.062
2013 Hay M, Patricios J, Collins R, Branfield A, Cook J, Handley CJ, September AV, Posthumus M, Collins M. Association of type XI collagen genes with chronic Achilles tendinopathy in independent populations from South Africa and Australia British Journal of Sports Medicine. 47: 569-574. PMID 23624467 DOI: 10.1136/bjsports-2013-092379  0.061
2010 Tirado CA, Valdez F, Klesse L, Karandikar NJ, Uddin N, Arbini A, Fustino N, Collins R, Patel S, Smart RL, Garcia R, Doolittle J, Chen W. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review. Cancer Genetics and Cytogenetics. 200: 54-9. PMID 20513535 DOI: 10.1016/j.cancergencyto.2010.03.001  0.059
2005 Seupaul RA, Collins R. Evidence-based emergency medicine/rational clinical examination abstract. Physical examination of the liver. Annals of Emergency Medicine. 45: 553-5. PMID 15861532 DOI: 10.1016/j.annemergmed.2005.01.014  0.059
2015 Denard B, Pavia-Jimenez A, Chen W, Williams NS, Naina H, Collins R, Brugarolas J, Ye J. Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome. Plos One. 10: e0129233. PMID 26110425 DOI: 10.1371/Journal.Pone.0129233  0.056
2008 Sadek H, Latif S, Collins R, Garry MG, Garry DJ. Use of ferumoxides for stem cell labeling. Regenerative Medicine. 3: 807-16. PMID 18947305 DOI: 10.2217/17460751.3.6.807  0.056
2022 Ashraf B, Jeon-Slaughter H, Nguyen H, Hoff F, Khatib J, Patel H, Vusirikala M, Collins R, Weinberg O, Chung S, Madanat Y. AML-522 Outcomes of Patients Treated With Venetoclax-Based Combination Therapy in Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms; Real World Data from a Single Center Cohort. Clinical Lymphoma, Myeloma & Leukemia. S259. PMID 36163856 DOI: 10.1016/S2152-2650(22)01311-8  0.051
2018 Tumati V, Trivedi L, Li HC, Patel P, Scaglioni PP, Vusirikala M, Sadeghi N, Rizvi S, Chen W, Wachsmann J, Collins R, Desai NB. Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 100: 1126-1132. PMID 29722657 DOI: 10.1016/j.ijrobp.2018.01.041  0.05
2012 Faderl S, Wetzler M, Rizzieri D, Schiller G, Jagasia M, Stuart R, Ganguly S, Avigan D, Craig M, Collins R, Maris M, Kovacsovics T, Goldberg S, Seiter K, Hari P, et al. Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2492-9. PMID 22585697 DOI: 10.1200/Jco.2011.37.9743  0.048
2004 Collins R. Fecal contamination of pastoral wetlands. Journal of Environmental Quality. 33: 1912-8. PMID 15356253 DOI: 10.2134/jeq2004.1912  0.048
2016 Tee JC, Klingbiel JF, Collins R, Lambert M, Coopoo Y. Preseason Functional Movement Screen component tests predict severe contact injuries in professional rugby union players. Journal of Strength and Conditioning Research / National Strength & Conditioning Association. PMID 26982969 DOI: 10.1519/JSC.0000000000001422  0.048
2007 Garcia-Palacios V, Chung HY, Choi SJ, Sarmasik A, Kurihara N, Lee JW, Galson DL, Collins R, Roodman GD. Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1. Bone. 40: 316-22. PMID 16996813 DOI: 10.1016/J.Bone.2006.08.004  0.048
2006 Navas TA, Mohindru M, Estes M, Ma JY, Sokol L, Pahanish P, Parmar S, Haghnazari E, Zhou L, Collins R, Kerr I, Nguyen AN, Xu Y, Platanias LC, List AA, et al. Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors. Blood. 108: 4170-7. PMID 16940419 DOI: 10.1182/Blood-2006-05-023093  0.047
2020 Scott J, Danos D, Collins R, Simonsen N, Leonardi C, Scribner R, Herd D. Structural racism in the built environment: Segregation and the overconcentration of alcohol outlets. Health & Place. 64: 102385. PMID 32755812 DOI: 10.1016/J.Healthplace.2020.102385  0.047
2008 Wang HY, Karandikar N, Payne D, Maleki A, Schultz BA, Collins R, McKenna RW. A 3-way collision tumor of the upper respiratory tract: a composite of 2 immunophenotypically distinct mantle cell lymphomas and a plasmacytoma. Human Pathology. 39: 781-7. PMID 18284935 DOI: 10.1016/j.humpath.2007.08.023  0.047
2017 Leonard JP, Kolibaba KS, Reeves JA, Tulpule A, Flinn IW, Kolevska T, Robles R, Flowers CR, Collins R, DiBella NJ, Papish SW, Venugopal P, Horodner A, Tabatabai A, Hajdenberg J, et al. Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017732784. PMID 28862883 DOI: 10.1200/JCO.2017.73.2784  0.046
2002 Castro-Malaspina H, Harris RE, Gajewski J, Ramsay N, Collins R, Dharan B, King R, Deeg HJ. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood. 99: 1943-51. PMID 11877264  0.044
2012 Schwellnus MP, Derman WE, Jordaan E, Page T, Lambert MI, Readhead C, Roberts C, Kohler R, Collins R, Kara S, Morris MI, Strauss O, Webb S. Elite athletes travelling to international destinations >5 time zone differences from their home country have a 2-3-fold increased risk of illness. British Journal of Sports Medicine. 46: 816-21. PMID 22875910 DOI: 10.1136/bjsports-2012-091395  0.043
2012 Schwellnus M, Derman W, Page T, Lambert M, Readhead C, Roberts C, Kohler R, Jordaan E, Collins R, Kara S, Morris I, Strauss O, Webb S. Illness during the 2010 Super 14 Rugby Union tournament - a prospective study involving 22 676 player days. British Journal of Sports Medicine. 46: 499-504. PMID 22554839 DOI: 10.1136/bjsports-2012-091046  0.042
2006 Garcia-Palacios V, Chung HY, Choi SJ, Kurihara N, Lee JW, Ehrlich LA, Collins R, Roodman GD. Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expression. Annals of the New York Academy of Sciences. 1068: 240-3. PMID 16831924 DOI: 10.1196/Annals.1346.048  0.042
2020 Churchill HRO, Fuda FS, Xu J, Deng M, Zhang CC, An Z, Zhang N, Chen P, Bergstrom C, Kansagra A, Collins R, John S, Koduru P, Chen W. Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation. Cytometry. Part B, Clinical Cytometry. PMID 32918786 DOI: 10.1002/cyto.b.21952  0.042
2011 Wakim JJ, Tirado CA, Chen W, Collins R. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Leukemia Research. 35: e151-3. PMID 21628071 DOI: 10.1016/j.leukres.2011.05.013  0.041
2011 Fridman JS, Scherle PA, Collins R, Burn T, Neilan CL, Hertel D, Contel N, Haley P, Thomas B, Shi J, Collier P, Rodgers JD, Shepard S, Metcalf B, Hollis G, et al. Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation. The Journal of Investigative Dermatology. 131: 1838-44. PMID 21677670 DOI: 10.1038/jid.2011.140  0.041
2010 Collins R, Cheng X. A case study in cross-talk: the histone lysine methyltransferases G9a and GLP Nucleic Acids Research. 38: 3503-3511. PMID 20159995 DOI: 10.1093/Nar/Gkq081  0.038
2022 Oertling E, Fuda F, Koduru P, Chen M, Weinberg O, Juntilla M, Jaso J, Vusirikala M, Chung S, Geethakumari PR, Madanat YF, Collins R, Gagan J, Chen W. Distinct mutational and clinicopathologic profiles characterize acute myeloid leukemia with cup-like nuclei. Leukemia Research. 124: 106995. PMID 36459761 DOI: 10.1016/j.leukres.2022.106995  0.038
2010 Mansour M, White D, Wernette C, Dennis J, Tao YX, Collins R, Parker L, Morrison E. Pancreatic neuronal melanocortin-4 receptor modulates serum insulin levels independent of leptin receptor. Endocrine. 37: 220-30. PMID 20963574 DOI: 10.1007/S12020-009-9289-5  0.034
2021 Bergstrom CP, Dahiya S, Chen W, Zhang CC, Zhu H, Yan J, Madanat Y, Patel P, Vusirkala M, Ramakrishnan P, Rizvi S, Chung S, Awan F, Anderson LD, Collins R, et al. Corrigendum to "The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement" [Leukemia Res. 100 (2021) 106480]. Leukemia Research. 106563. PMID 33781572 DOI: 10.1016/j.leukres.2021.106563  0.034
2003 Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, Christensen L, Baker J, Altrabulsi B, Osowski L, McCormack J, Fichtel L, Dawson DB, Domiati-Saad R, Stone M, et al. Liver transplant-associated graft-versus-host disease. Transplantation. 75: 118-26. PMID 12544883 DOI: 10.1097/00007890-200004271-00034  0.033
2016 Chen P, Chu A, Zia H, Koduru P, Collins R, Winick N, Fuda F, Chen W. CD25 Expression in B Lymphoblastic Leukemia/Lymphoma Predicts t(9;22)(q34;q11)/Philadelphia Chromosome Translocation (Ph) and Is Associated With Residual Disease in Ph-Negative Patients. American Journal of Clinical Pathology. 146: 632-638. PMID 28430957 DOI: 10.1093/ajcp/aqw178  0.032
2021 DiNardo CD, Stein EM, Pigneux A, Altman JK, Collins R, Erba HP, Watts JM, Uy GL, Winkler T, Wang H, Choe S, Liu H, Wu B, Kapsalis SM, Roboz GJ, et al. Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant. Leukemia. PMID 33772143 DOI: 10.1038/s41375-021-01229-x  0.028
2011 Rakheja D, Konoplev S, Su M, Wheeler D, Muzny DM, Ruvolo VR, Collins R, Karandikar NJ, Andreeff M, Medeiros LJ, Chen W. High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei. British Journal of Haematology. 155: 125-8. PMID 21480859 DOI: 10.1111/J.1365-2141.2011.08646.X  0.026
2015 Kougias P, Collins R, Pastorek N, Sharath S, Barshes NR, McCulloch K, Pisimisis G, Berger DH. Comparison of domain-specific cognitive function after carotid endarterectomy and stenting. Journal of Vascular Surgery. 62: 355-61. PMID 26211378 DOI: 10.1016/J.Jvs.2015.02.057  0.026
2004 Shivapurkar N, Takahashi T, Reddy J, Zheng Y, Stastny V, Collins R, Toyooka S, Suzuki M, Parikh G, Asplund S, Kroft SH, Timmons C, McKenna RW, Feng Z, Gazdar AF. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Research. 64: 3757-60. PMID 15172980 DOI: 10.1158/0008-5472.Can-03-3307  0.023
2015 Steinhaus DA, Waks JW, Collins R, Kleckner K, Kramer DB, Zimetbaum PJ. Effect of Smaller Left Ventricular Capture Threshold Safety Margins to Improve Device Longevity in Recipients of Cardiac Resynchronization-Defibrillation Therapy. The American Journal of Cardiology. 116: 85-7. PMID 25933732 DOI: 10.1016/J.Amjcard.2015.03.047  0.022
2014 O'Neil J, Steele GK, Weinstein E, Collins R, Talty J, Bull MJ. Ambulance transport of noncritical children: emergency medical service providers' knowledge, opinions, and practice. Clinical Pediatrics. 53: 250-5. PMID 24408898 DOI: 10.1177/0009922813517168  0.015
2009 Golji J, Collins R, Mofrad MR. Molecular mechanics of the alpha-actinin rod domain: bending, torsional, and extensional behavior. Plos Computational Biology. 5: e1000389. PMID 19436721 DOI: 10.1371/journal.pcbi.1000389  0.011
2023 Berman E, Shah NP, Deninger M, Altman JK, Amaya M, Begna K, Bhatia R, Chan O, Collins R, Curtin P, DeAngelo DJ, Drazer M, Maness L, Metheny L, Mohan S, et al. CML and the WHO: Why? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2301689. PMID 38086008 DOI: 10.1200/JCO.23.01689  0.01
2022 Hamdan H, Luu L, Opsahl M, Weinberg O, Fuda F, Koduru P, Wilson K, Gagan J, Ramakrishnan Geethakumari P, Collins R, Chen W. Genomic profile of TdT MYC/BCL2 rearranged high-grade B-cell lymphoma supporting its diagnosis as mature aggressive lymphoma. Cytometry. Part B, Clinical Cytometry. PMID 36102633 DOI: 10.1002/cyto.b.22092  0.01
2019 Neff R, Collins R, Backes F. Dermatofibrosarcoma protuberans: A rare and devastating tumor of the vulva. Gynecologic Oncology Reports. 28: 9-11. PMID 30733992 DOI: 10.1016/j.gore.2019.01.006  0.01
2012 Patricios JS, Collins R, Roberts C. Zurich 2012: our cohort of 'concussionologists' - conveying consensus. British Journal of Sports Medicine. 47: 9-11. PMID 23077288 DOI: 10.1136/bjsports-2012-091756  0.01
2007 Chitale S, Collins R, Hull S, Smith E, Irving S. Is the current practice providing an integrated approach to the management of LUTS and ED in primary care? An audit and literature review. The Journal of Sexual Medicine. 4: 1713-25. PMID 17908234 DOI: 10.1111/j.1743-6109.2007.00598.x  0.01
Hide low-probability matches.